Skip to main content
Premium Trial:

Request an Annual Quote

Proteome BioKnowledge Library, AFCS-Nature Molecule Pages, SCOP, Ensembl 19, Bioconductor, and VEGA 1.5.1


Incyte is offering free access to HIV- and AIDS-related data in its Proteome BioKnowledge Library during December as part of its monthly Disease Spotlight program. The HIV and AIDS Disease Spotlight provides 25 protein reports related to HIV and AIDS with curated annotations based on relevant publications. The data is available at

The Nature Publishing Group and the Alliance for Cellular Signaling have launched the AfCS-Nature Molecule Pages, a database of curated information about more than 3,000 proteins involved in cellular signaling. The pages, available at, are a step toward the goal of creating a complete computer simulation of cellular behavior, according to the AfCS.

A new SCOP (structural classification of proteins) release (1.65) is available at The new version contains 20,619 PDB entries and 54,745 domains.

Ensembl 19 is available at New data includes an updated gene build for the NCBI 34 assembly, including 200-300 improved predictions produced as a result of corrections in the gene building soft-ware. The build contains 23,531 gene predictions with 31,609 transcripts.

A Bioconductor package using John Storey’s Q-value code [BioInform 08-04-03] is available at

VEGA 1.5.1, a program to convert, manage, and visualize 3D structures, is available from Milan’s Istituto di Chimica Farmaceutica e Tossicologica at New functions include the capability to add hydrogen molecules; and RMSD cal-culation and Accelrys archive file (.arc) support in the trajectory analysis.

Filed under

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.